1200 related articles for article (PubMed ID: 26944194)
1. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
[TBL] [Abstract][Full Text] [Related]
2. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq.
Lo R; Matthews J
Toxicol Sci; 2012 Dec; 130(2):349-61. PubMed ID: 22903824
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
[TBL] [Abstract][Full Text] [Related]
4. Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.
Attignon EA; Leblanc AF; Le-Grand B; Duval C; Aggerbeck M; Rouach H; Blanc EB
Arch Toxicol; 2017 Jan; 91(1):313-324. PubMed ID: 27055685
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide mapping and analysis of aryl hydrocarbon receptor (AHR)- and aryl hydrocarbon receptor repressor (AHRR)-binding sites in human breast cancer cells.
Yang SY; Ahmed S; Satheesh SV; Matthews J
Arch Toxicol; 2018 Jan; 92(1):225-240. PubMed ID: 28681081
[TBL] [Abstract][Full Text] [Related]
6. Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells.
Salisbury TB; Tomblin JK; Primerano DA; Boskovic G; Fan J; Mehmi I; Fletcher J; Santanam N; Hurn E; Morris GZ; Denvir J
Biochem Pharmacol; 2014 Oct; 91(3):390-9. PubMed ID: 24971714
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
Ahmed S; Wang A; Celius T; Matthews J
Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.
Abdelrahim M; Smith R; Safe S
Mol Pharmacol; 2003 Jun; 63(6):1373-81. PubMed ID: 12761348
[TBL] [Abstract][Full Text] [Related]
10. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
Le Vee M; Jouan E; Lecureur V; Fardel O
Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor-ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism.
Su HH; Lin HT; Suen JL; Sheu CC; Yokoyama KK; Huang SK; Cheng CM
Toxicology; 2016 Aug; 370():116-126. PubMed ID: 27697457
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
14. Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.
Ernst J; Jann JC; Biemann R; Koch HM; Fischer B
Mol Hum Reprod; 2014 Sep; 20(9):919-28. PubMed ID: 24950685
[TBL] [Abstract][Full Text] [Related]
15. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells.
Degner SC; Papoutsis AJ; Selmin O; Romagnolo DF
J Nutr; 2009 Jan; 139(1):26-32. PubMed ID: 19056653
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor (AHR) and AHR nuclear translocator (ARNT) expression in Baikal seal (Pusa sibirica) and association with 2,3,7,8-TCDD toxic equivalents and CYP1 expression levels.
Kim EY; Iwata H; Suda T; Tanabe S; Amano M; Miyazaki N; Petrov EA
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jul; 141(3):281-91. PubMed ID: 16111922
[TBL] [Abstract][Full Text] [Related]
17. L-leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): kinetics, regulation by estrogen and molecular identity of the transporter.
Shennan DB; Thomson J; Gow IF; Travers MT; Barber MC
Biochim Biophys Acta; 2004 Aug; 1664(2):206-16. PubMed ID: 15328053
[TBL] [Abstract][Full Text] [Related]
18. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
Son DS; Rozman KK
Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.
Beischlag TV; Wang S; Rose DW; Torchia J; Reisz-Porszasz S; Muhammad K; Nelson WE; Probst MR; Rosenfeld MG; Hankinson O
Mol Cell Biol; 2002 Jun; 22(12):4319-33. PubMed ID: 12024042
[TBL] [Abstract][Full Text] [Related]
20. Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver.
Qu X; Metz RP; Porter WW; Cassone VM; Earnest DJ
Toxicol Appl Pharmacol; 2009 Feb; 234(3):370-7. PubMed ID: 19038280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
